Illinois regulators have released the state's 2026 Annual Cannabis Report, pointing to record sales and expanded access during Fiscal Year 2026.

The Illinois Department of Financial and Professional Regulation and the Cannabis Regulation Oversight Office released the report, which covers cannabis licensing, regulation, public health, public safety and economic development.

The report reflects the passage of SB 3222, the Cannabis and Hemp Omnibus, signed into law in June 2026. The law allows adult-use dispensaries across Illinois to opt in to serving medical cannabis patients, reduces certain barriers to entry and increases transparency around cannabis business ownership.

"Fiscal Year 2026 was an important year for Illinois' cannabis program, and the changes we have been implementing from SB 3222 continue to strengthen the regulatory framework and build on the progress we have made since adult-use cannabis was first legalized," IDFPR Secretary Mario Treto, Jr. said.

Among the report's highlights:

  • More than 5 million adult-use items were sold in July 2026, the highest monthly total to date. August 2026 sales totaled nearly 4.9 million adult-use items, a 9 percent increase compared to August 2025.
  • IDFPR issued 29 operational dispensary licenses during the fiscal year, increasing retail locations by more than 10 percent.
  • IDFPR conducted 755 dispensary inspections, up from 625 the year before, and expanded its inspection staff from 11 to 16 inspectors. The department reported no mandatory cannabis product recalls in FY26.
  • SB 3222 increased patient options, added new qualifying medical conditions, reduced certification fees and codified the ability for telehealth certification visits.

Cannabis Regulation Oversight Officer Erin Johnson said the state saw a record number of sales last year, "with the best prices yet for Illinois consumers."

The report compiles required annual reporting from IDFPR, the Illinois Department of Agriculture, Illinois State Police, the Adult Use Cannabis Health Advisory Committee, DCEO and the Illinois Department of Public Health.